Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02

Arrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of $0.02, versus $0.04 reported last year. Revenue for the quarter came in at $5.13 million, versus $5.66 million reported last year.

For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Movano (MOVE) Misses Q2 EPS by 195c